Viewing nowCombinationARBITES Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201606338 · Approved 2016.10.28 · Insurance code 647804470
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower and control blood pressure in patients with essential hypertension who are not adequately controlled with either telmisartan or amlodipine monotherapy. This contributes to reducing the risk of cardiovascular complications and maintaining healthy vascular conditions. It is important to take this medication regularly for hypertension management, and it is used to steadily improve blood pressure.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). Before starting treatment with this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and gradually increase the dose.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose a serious risk to the fetus, especially during the second and third trimesters of pregnancy, and should not be used during pregnancy. If pregnancy is planned or confirmed, the use of this medication should be immediately discontinued, and other safe treatments should be sought. This medication should not be used in patients with certain conditions, such as severe liver disease, obstructive biliary disease, left ventricular outflow obstruction, severe hypotension, or cardiac shock. Additionally, in diabetic patients with severely reduced kidney function, the combination of this medication with certain drugs should be avoided. Special precautions are required for patients with primary aldosteronism or aortic stenosis, hypertrophic cardiomyopathy. Caution should also be exercised when administering to patients with impaired liver function, with dosage adjustments necessary. Patients with gastrointestinal conditions should be aware of the risk of gastrointestinal bleeding when taking this medication. Patients with renal vascular disease may experience increased risk of hypotension or renal failure when taking this medication, and regular blood tests and monitoring are necessary. Elderly patients may be more sensitive to this medication; therefore, it is advisable to start with a lower initial dose and gradually increase it. The risk of side effects such as hypotension, renal failure, and hyperkalemia may increase when this medication is combined with other antihypertensives, so caution is required during combined therapy. Overdosage can result in symptoms such as hypotension, dizziness, and irregular heart rate, and immediate medical attention should be sought. During the use of this medication, drowsiness or dizziness may occur, so caution is recommended when driving or operating hazardous machinery. Nursing mothers are advised not to take this medication and should consult a healthcare professional if necessary. The safety and efficacy of this medication have not been sufficiently established in children and adolescents, hence its use is not recommended. This medication should be kept out of reach of children and should not be transferred to other containers. Adherence to the prescribed dosages and consultation with a healthcare professional if adverse reactions occur is essential.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is advisable to store the medication at room temperature, between 1 to 30 degrees Celsius.
White to light yellow and pale blue, bi-convex oval double tablet
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.